Jeffrey H. Newcorn, MD

JCP
Emerging Therapies for Attention-Deficit/Hyperactivity Disorder
DELETE CME Institute Showcase

August 9, 2023

While patients with ADHD today still face numerous unmet needs, a number of newer pharmacologic agents and devices with potential advantages over traditional therapies have emerged and gained regulatory...
Jeffrey H. Newcorn
JCP
Original Research

June 29, 2021

Many patients with ADHD have “sluggish cognitive tempo,” characterized by daydreaming, being underactive, and feeling spacey and lethargic. This RCT evaluated the use of lisdexamfetamine in adults to reduce...
Lenard A. Adler, Terry L. Leon, Taylor M. Sardoff, et al
JCP
Original Research

December 15, 2013

Linda A. Wietecha, Dustin D. Ruff, Albert J. Allen, et al
JCP
Original Research

December 15, 2012

Iris Manor, Rachel Ben-Hayun, Judith Aharon-Peretz, et al
JCP
Academic Highlights

July 15, 2011

Lenard A. Adler, Gregory W. Mattingly, C. Brendan Montano, et al
JCP
Educational Activity

June 15, 2011

Lenard A. Adler, Jeffrey H. Newcorn
JCP
Educational Activity

May 15, 2011

Lenard A. Adler, Jeffrey H. Newcorn
JCP
Educational Activity

April 15, 2011

Lenard A. Adler, Russell A. Barkley, Jeffrey H. Newcorn
JCP
Educational Activity

March 15, 2011

Jeffrey H. Newcorn
PCC
Academic Highlights

February 16, 2009

Russel A. Barkley, Jeffrey H. Newcorn
JCP
Educational Activity

February 16, 2009

Jeffrey H. Newcorn
JCP
Article

September 30, 2008

Carlin J. Miller, Janine D. Flory, Scott R. Miller, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe